Study details
Enrolling now
Use of tAN® in Alcohol Withdrawal Management
Erin Deneke
NCT IDNCT06771037ClinicalTrials.gov data as of Apr 2026
Target enrollment
60
Study length
about 2.2 years
Ages
18–65
Locations
1 site in PA
What this study is about
Researchers are testing if Transcutaneous Auricular Neurostimulation (tAN®) can help manage alcohol withdrawal. The trial will involve delivering small electrical stimulations to the Vagus and Trigeminal nerves using a device. Participants will be enrolled within 24 hours of entering treatment for alcohol withdrawal management.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Use Transcutaneous Auricular Neurostimulation (tAN)
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
Randomized & Blinded
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Body systems
Psychiatry / Mental Health